Network systems underlying traditional Chinese medicine syndrome and herb formula

Current Bioinformatics

Volumn 4, Issue 3, 2009, Pages 188-196

  Li, Shao ^a  

^a Tsinghua University   (China)

Author keywords

Herb formula; Map of phenotype network biological network herb network; Network biomarker; Systems medicine; TCM syndrome; Traditional Chinese medicine systems bioinformatics

Indexed keywords

BIOINFORMATICS; BIOLOGICAL SYSTEMS; COMPUTATION THEORY;

BIOLOGICAL NETWORKS; HERB FORMULA; MAP OF PHENOTYPE NETWORK-BIOLOGICAL NETWORK-HERB NETWORK; NETWORK BIOMARKER; NETWORK SYSTEMS; SYSTEM MEDICINE; TRADITIONAL CHINESE MEDICINE; TRADITIONAL CHINESE MEDICINE SYNDROME; TRADITIONAL CHINESE MEDICINE SYSTEM BIOINFORMATIC;

BIOMARKERS;

CHINESE DRUG; FU FANG; HERBACEOUS AGENT; NEUROTROPIN; PROTEIN P53; QING LUO YIN; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY TRACT DISEASE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOINFORMATICS; CHINESE MEDICINE; CHRONIC GASTRITIS; COMPUTER MODEL; DISEASE ASSOCIATION; DISEASE MARKER; DNA DAMAGE; DRUG INDUCED DISEASE; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; TRADITIONAL CHINESE MEDICINE SYNDROME;

EID: 70549112019     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489309789071129     Document Type: Review

References (74)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75.
2. Fontanarosa PB, Lundberg GD. Alternative medicine meets science. JAMA 1998; 280: 1618-9.
3. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685-90.
4. Lage K, Karlberg EO, Storling ZM, et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotech 2007; 25: 309-16.
5. Wu XB, Jiang R, Zhang MQ, Li S. Network-based global inference of human disease genes. Mol Syst Biol 2008; 4: 189.
6. Li S, Wu L, Zhang Z. Constructing biological networks through combined literature mining and microarray analysis: a LMMA approach. Bioinformatics 2006; 22: 2143-50.
7. Xue H, Xian B, Dong D, et al. A modular network model of aging. Mol Syst Biol 2007; 3: 147.
8. Kitano H. Systems biology: a brief overview. Science 2002; 295: 1662-4.
9. Hoessel R, Leclerc S, Endicott JA, et al. Systems biology and new technologies enable predictive and preventative medicine. Science 2004; 306: 640-3.
10. Verpoorte R, Choi YH, Kim HK. Ethnopharmacology and systems biology: a perfect holistic match. J Ethnopharmacol 2005; 100: 53-6.
11. Patwardhan B, Gautam M. Botanical immunodrugs: scope and opportunities. Drug Discov Today 2005; 10: 495-502.
12. Qiu J. China plans to modernize traditional medicine. Nature 2007; 446: 590-1.
13. Qiu J. Traditional medicine: a culture in the balance. Nature 2007; 448: 126-8.
14. Joyce AR, Palsson BØ. The model organism as a system: integrating 'omics' data sets. Nat Rev Mol Cell Biol 2006; 7: 198-210.
15. Palsson B. The challenges of in silico biology. Nat Biotech 2000; 18: 1147-50.
16. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004; 5: 101-13.
17. Bell IR, Koithan M. Models for the study of whole systems. Integr Cancer Ther 2006; 5: 293-307.
18. Hunter T. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling. Cell 1995; 80: 225-36.
19. Ou B, Huang D, Hampsch-Woodill M, Flanagan JA. When east meets west: the relationship between yin-yang and antioxidation-oxidation. FASEB J 2003; 17: 127-9.
20. Lu B, Pang PT, Woo NH. The Yin and Yang of neurotrophin action. Nat Rev Neurosci 2005; 6: 603-14.
21. Zhang J. Yin and yang interplay of IFN-γ in inflammation and autoimmune disease. J Clin Invest 2007; 117: 871-3.
22. Xue T, Roy R. Studying traditional Chinese medicine. Science 2003; 300: 740-1.
23. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotech 2004; 22: 1253-9.
24. Gu CD. The inner classic of the yellow emperor, essential questions (Chinese name: Huangdi Neijing, Suwen). People's Medical Publishing House, Beijing 1956.
25. Li Y, Li S, Lu AP. Comparative analysis via data mining on the clinical features of Western medicine and Chinese medicine in diagnosing rheumatoid arthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26: 988-91.
26. Li S, Wang R, Zhang Y, et al. Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS. Am J Chin Med 2006; 34: 937-47.
27. He Y, Lu A, Lu C, et al. Symptom combinations assessed in traditional chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis. Am J Chin Med 2008; 36: 675-83.
28. Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol 2003; 9: 755-8.
29. Barabási AL. Network medicine--from obesity to the "diseasome". N Engl J Med 2007; 357: 404-7.
30. Brunner HG, van Driel MA. From syndrome families to functional genomics. Nat Rev Genet 2004; 5: 545-51.
31. Oti M, Brunner HG. The modular nature of genetic diseases. Clin Genet 2007; 71: 1-11.
32. Hayden EC. Biological tools revamp disease classification. Nature 2008; 453: 709.
33. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol 2007; 1: 51-60.
34. Besedovsky HO, Sorkin E. Network of immune-neuroendocrine interactions. Clin Exp Immunol 1977; 27: 1-12.
35. Roth J, LeRoith D, Shiloach J, Rosenzweig JL, Lesniak MA, Havrankova J. The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology. N Engl J Med 1982; 306: 523-7.
36. Hsu CH, Yu MC, Lee CH, Lee TC, Yang SY. High eosinophil cationic protein level in asthamatic patients with "Heat" Zheng. Am J Chin Med 2003; 31: 277-83.
37. Shen ZY, Huang JH, Chen WH. Comparison of gene expression profiles between rats of Shen deficiency syndrome and Shen-yang deficiency syndrome differentiated according to therapeutic efficacy of drugs used. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27: 135-7.
38. Ma XJ, Yin HJ, Chen KJ. Investigation of gene expression profiles in patients with blood stasis syndrome. Zhong Xi Yi Jie He Xue Bao 2008; 6: 355-60.
39. Xiao C, Zhao LH, Lu C, et al. Study on the differential gene expression of peripheral CD4+ among rheumatoid arthritis patients of cold or heat syndrome type with or without rheumatoid factor. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26: 689-93.
40. Zhou X, Liu B, Wu Z, Feng Y. Integrative mining of traditional Chinese medicine literature and MEDLINE for functional gene networks. Artif Intell Med 2007; 41: 87-104.
41. Yang L, Wang M, Wu W, Zhang L. Transcriptome analysis of Cold syndrome using microarray. Am J Chin Med 2007; 35: 609-20.
42. Johnson RW, Propes MJ, Shavit Y. Corticosterone modulates behavioral and metabolic effects of lipopolysaccharide. Am J Physiol 1996; 270: R192-8.
43. Zhuang Y, Li S, Li Y. dbNEI: a specific database for neuroendocrine- immune interactions. Neuro Endocrinol Lett 2006; 27: 53-9.
44. Zhang J, Ma T, Li YD, Li S. dbNEI2.0: building multilayer network for drug-NEI-disease. Bioinformatics 2008; 24: 2409-11.
45. Tolle V, Low MJ. Genes, environment, neuroendocrine circuits, and energy balance, Drug Discov Today Dis Models 2004; 1: 365-72.
46. Kang GL, Li S, Zhang JF. Entropy-based model for interpreting life systems in traditional Chinese medicine. Evid Based Complement Alternat Med 2008; 5: 273-9.
47. Sinha G. Medicine of the masses. Nat Med 2005; 11: 9-10.
48. Stone R. Lifting the veil on traditional Chinese medicine. Science 2008; 319: 709-10.
49. Keith CT, Borisy AA, Stockwell BR. Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 2005; 4: 71-8.
50. Wang M, Lamers RJ, Korthout HA, et al. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res 2005; 19: 173-82.
51. Chen M, Su M, Zhao L, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 2006; 5: 995-1002.
52. Qiu Y, Chen M, Su M, et al. Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced 'kidney-deficiency syndrome'. Chin Med 2008; 3: 3.
53. Yue QX, Cao ZW, Guan SH, et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 2008; 7: 949-61.
54. Cheng WY, Wu SL, Hsiang CY, et al. Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. Am J Chin Med 2008; 36: 783-97.
55. Ehrman TM, Barlow DJ, Hylands PJ. Phytochemical informatics of traditional Chinese medicine and therapeutic relevance. J Chem Inf Model 2007; 47: 2316-34.
56. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146: 857-68.
57. Li S. Framework and practice of network-based studies for Chinese herbal formula. Zhong Xi Yi Jie He Xue Bao 2007; 5, 489-93.
58. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine 2001; 8: 401-9.
59. Ung CY, Li H, Cao ZW, Li YX, Chen YZ. Are herb-pairs of traditional Chinese medicine distinguishable from others? Pattern analysis and artificial intelligence classification study of traditionally defined herbal properties. J Ethnopharmacol 2007; 111: 371-7.
60. Kan WL, Cho CH, Rudd JA, Lin G. Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells. J Ethnopharmacol 2008; 120: 36-43.
61. Adams LS, Seeram NP, Hardy ML, Carpenter C, Heber D. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med 2006; 3: 117-24.
62. Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008; 105: 4826-31.
63. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 2006; 27: 297-309.
64. Li S, Lu AP, Wang YY, Li YD. Suppressive effects of a Chinese herbal medicine Qing-luo-yin extract on the angiogenesis of collagen-induced arthritis in rats. Am J Chin Med 2003; 31: 713-20.
65. Li S, Lu AP, Li, B, Wang YY. Circadian rhythms on hypothalamic-pituitary- adrenal axis hormones and cytokines of collagen induced arthritis in rats. J Autoimmun 2004; 22: 277-85.
66. Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
67. Lu J, Kasama T, Kobayashi K, et al. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 2000; 164: 5922-7.
68. Wu M, Ma C, Wu Y, Li S. Simultaneous LC analysis of five bioactive alkaloids in an anti-angiogenesis herbal formula, Qing-Luo-Yin. Chromatographia 2008; 68: 579-85.
69. Li S, Wu M. Composition and its use as effective constituent of a medicine having anti-angiogenesis synergy effect. China invention patent ZL200610114226.X, 2006
70. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005; 26: 178-82.
71. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007; 130: 769-74.
72. Kitano H. A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 2007; 6: 202-10.
73. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-30.
74. Abdollahi A, Schwager C, Kleeff J, et al. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 2007; 104: 12890-5.